Amarin Corp Plc (AMRN)

[FishyFingers]

"$150M". Thanks. I thought it would have been a little higher going from that article where it states:

After examining 10 pharmaceutical companies and 106 randomly selected drugs that were first tested in human clinical trials between 1995 and 2007, Tufts estimated that the true cost to bring a drug to market was $2.56 billion (in 2013 dollars).

https://www.fool.com/investing/general/2016/04/30/the-cost-of-developing-an-fda-approved-drug-is-tru.aspx

There's obviously a big discrepancy there between $150M and $2.56B but I suppose the fact that VASCEPA (formerly Miraxion) already had a bunch of pre-existing R&D before entering the PHASE 3 trials for the TG indications saved some money.